研究成果・実績

Will digital technology address the challenges of drug development in psychiatry?

Kishimoto T. World Psychiatry. 2023 Feb;22(1):79-80.

Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocol.

Kishimoto T, Kinoshita S, Kikuchi T, Bun S, Kitazawa M, Horigome T, Tazawa Y, Takamiya A, Hirano J, Mimura M, Liang KC, Koga N, Ochiai Y, Ito H, Miyamae Y, Tsujimoto Y, Sakuma K, Kida H, Miura G, Kawade Y, Goto A, Yoshino F. Front Psychiatry. 2022 Dec 21;13:1025517.

Understanding psychiatric illness through natural language processing (UNDERPIN): Rationale, design, and methodology. Front Psychiatry.

Kishimoto T, Nakamura H, Kano Y, Eguchi Y, Kitazawa M, Liang KC, Kudo K, Sento A, Takamiya A, Horigome T, Yamasaki T, Sunami Y, Kikuchi T, Nakajima K, Tomita M, Bun S, Momota Y, Sawada K, Murakami J, Takahashi H, Mimura M. 2022 Dec 1;13:954703.

Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.

Fukumoto K, Kodaka F, Hasegawa N, Muraoka H, Hori H, Ichihashi K, Yasuda Y, Iida H, Ohi K, Ochi S, Ide K, Hashimoto N, Usami M, Nakamura T, Komatsu H, Okada T, Nagasawa T, Furihata R, Atake K, Kido M, Kikuchi S, Yamagata H, Kishimoto T, Makinodan M, Horai T, Takeshima M, Kubota C, Asami T, Katsumoto E, Hishimoto A, Onitsuka T, Matsumoto J, Miura K, Yamada H, Yasui-Furukori N, Watanabe K, Inada K, Otsuka K, Hashimoto R. Neuropsychopharmacol Rep. 2023 Mar;43(1):33-39.

人工知能技術による精神疾患自動診断への挑戦.

佐藤真一, 岸本泰士郎, 相澤清晴, 山崎俊彦, 狩野芳伸. 人工知能. 2022; 37(6); 774.

中央評価, 遠隔モニタリング―種々の遠隔医療の今後の展開―.

岸本泰士郎, 木下翔太郎. オンライン診療, 精神神経学雑誌. 2022; 124(2); 126-133.

Development of Individual Fitness Score for conformity of prescriptions to the “Guidelines for Pharmacological Therapy of Schizophrenia”.

Inada K, Fukumoto K, Hasegawa N, Yasuda Y, Yamada H, Hori H, Ichihashi K, Iida H, Ohi K, Muraoka H, Kodaka F, Ide K, Hashimoto N, Iga J, Ogasawara K, Atake K, Takaesu Y, Nagasawa T, Komatsu H, Okada T, Furihata R, Kido M, Kikuchi S, Kubota C, Makinodan M, Ochi S, Takeshima M, Yamagata H, Matsumoto J, Miura K, Usami M, Kishimoto T, Onitsuka T, Katsumoto E, Hishimoto A, Numata S, Yasui-Furukori N, Watanabe K, Hashimoto R. Neuropsychopharmacol Rep. 2022 Dec;42(4):502-509.

オンライン診療の適正な普及に関するヒアリング調査 : 現状把握と課題分析

木下翔太郎, 成瀨浩史, 吉村健佑, 岸本泰士郎, 榎戸芙佐子, 押淵英弘, 兼子幸一, 瀬戸秀文, 辻本哲士, 長尾喜一郎, 三野進, 村田昌彦, 米田博, 稲垣中. 精神神経学雑誌, 2022; 124(1); 16-27.

Is this the end of precision medicine? Or the beginning?

Takamiya A, Kishimoto T. Lancet Psychiatry. 2022 Nov;9(11):849-850.

Case report: Non-Alzheimer’s disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET.

Momota Y, Konishi M, Takahata K, Kishimoto T, Tezuka T, Bun S, Tabuchi H, Ito D, Mimura M. Front Neurol. 2022 Nov 15;13:1049113.